Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres

Authors :: Ingrid A Rojas
Nancy H. Covell
Carlos T Jackson
Nina Schooler
T. Scott Stroup
Joseph P. McEvoy
Susan M. Essock
Source :: The Journal of Clinical Psychiatry. 73:669-675
Publication Year :: 2012
Publisher :: Physicians Postgraduate Press, Inc, 2012.
Abstract: Objective This multisite randomized trial addressed risks and benefits of staying on long-acting injectable haloperidol or fluphenazine versus switching to long-acting injectable risperidone microspheres.

Subjects :: Fluphenazine
Intention-to-treat analysis
Risperidone
business.industry
Haloperidol Decanoate
Pharmacology
law.invention
Microsphere
Psychiatry and Mental health
Long acting
Randomized controlled trial
law
Haloperidol
medicine
business
medicine.drug

Full Text Access

Tools